Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 4,969,000 | 5,526,000 | 6,638,000 | 6,183,000 | 5,400,000 |
| Cost of Goods | 3,902,000 | 4,463,000 | 4,667,000 | 4,438,000 | 4,297,000 |
| Gross Profit | 1,067,000 | 1,063,000 | 1,971,000 | 1,745,000 | 1,103,000 |
| Operating Expenses | 700,000 | 715,000 | 788,000 | 764,000 | 1,197,000 |
| Operating Income | 367,000 | 348,000 | 1,183,000 | 981,000 | -94,000 |
| Interest Expense | 210,000 | 208,000 | 195,000 | 214,000 | 219,000 |
| Other Income | 22,000 | -264,000 | 167,000 | 145,000 | 302,000 |
| Pre-tax Income | 179,000 | -124,000 | 1,155,000 | 912,000 | -11,000 |
| Income Tax | -40,000 | -72,000 | 159,000 | 165,000 | -18,000 |
| Net Income Continuous | 219,000 | -52,000 | 996,000 | 747,000 | 7,000 |
| Minority Interests | N/A | N/A | 1,000 | 1,000 | N/A |
| Net Income | $219,000 | $-52,000 | $995,000 | $746,000 | $7,000 |
| EPS Basic Total Ops | 1.33 | -0.32 | 5.62 | 4.04 | 0.04 |
| EPS Basic Continuous Ops | 1.33 | -0.32 | 5.63 | 4.04 | 0.04 |
| EPS Diluted Total Ops | 1.32 | -0.32 | 5.45 | 3.91 | 0.04 |
| EPS Diluted Continuous Ops | 1.32 | -0.32 | 5.46 | 3.91 | 0.04 |
| EPS Diluted Before Non-Recurring Items | 1.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $696,000 | $668,000 | $1,478,000 | $1,267,000 | $206,000 |